The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Calvin Sandra since 2022.
This trader's CIK number is 1882909.
At the time of last reporting, Calvin Sandra was the SVP, CHIEF ACCOUNTING OFFICER of Travere Therapeutics, Inc.. (stock ticker symbol TVTX).
Also see all insider trading activities at Travere Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | TVTX | 0 | $0 | 58,517 | $1,440,981 | 45,000 | $754,785 |
| 2024 | TVTX | 0 | $0 | 15,820 | $253,567 | 15,000 | $190,050 |
| 2023 | TVTX | 0 | $0 | 2,589 | $53,617 | 0 | $0 |
| 2022 | TVTX | 0 | $0 | 2,962 | $73,011 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-11 | TVTX | Option Ex | 45,000 | 16.77 | 754,785 |
| 2025-02-11 | TVTX | Sale | 54,244 | 25.00 | 1,356,100 |
| 2025-02-03 | TVTX | Sale | 3,348 | 20.12 | 67,361 |
| 2025-01-22 | TVTX | Sale | 925 | 18.94 | 17,520 |
| 2024-11-25 | TVTX | Option Ex | 15,000 | 12.67 | 190,050 |
| 2024-11-25 | TVTX | Sale | 12,090 | 18.30 | 221,259 |
| 2024-02-01 | TVTX | Sale | 2,820 | 8.53 | 24,057 |
| 2024-01-23 | TVTX | Sale | 910 | 9.07 | 8,251 |
| 2023-05-10 | TVTX | Sale | 436 | 16.59 | 7,233 |
| 2023-05-11 | TVTX | Sale | 122 | 16.12 | 1,966 |
| 2023-02-01 | TVTX | Sale | 1,671 | 21.75 | 36,347 |
| 2023-02-02 | TVTX | Sale | 360 | 22.42 | 8,071 |
| 2022-09-13 | TVTX | Sale | 349 | 28.00 | 9,772 |
| 2022-05-10 | TVTX | Sale | 436 | 21.51 | 9,378 |
| 2022-05-11 | TVTX | Sale | 445 | 21.92 | 9,756 |
| 2022-01-31 | TVTX | Sale | 798 | 26.51 | 21,151 |
| 2022-01-24 | TVTX | Sale | 934 | 24.58 | 22,954 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Calvin Sandra (SVP, CHIEF ACCOUNTING OFFICER of Travere Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.